Clinical Trials on Dysplastic Nevi
Total 3767 results
-
Novartis PharmaceuticalsCompletedMelanomaUnited States, Belgium, Canada, Spain, United Kingdom, Netherlands, Argentina, Australia, Austria, Brazil, Czechia, Denmark, France, Germany, Greece, Israel, Italy, Japan, New Zealand, Norway, Poland, Russian Federation, Sweden, Switz... and more
-
Memorial Sloan Kettering Cancer CenterSchering-PloughCompleted
-
BioNTech SECompleted
-
Memorial Sloan Kettering Cancer CenterArray BioPharmaCompleted
-
QBiotics Group LimitedTerminated
-
QBiotics Group LimitedMerck Sharp & Dohme LLCTerminated
-
Melanoma and Skin Cancer Trials LimitedTrans Tasman Radiation Oncology GroupActive, not recruiting
-
Memorial Sloan Kettering Cancer CenterRockefeller UniversityCompleted
-
University Hospital, GhentGZA Ziekenhuizen Campus Sint-AugustinusCompleted
-
Parker Institute for Cancer ImmunotherapyBristol-Myers SquibbCompleted
-
Centre Antoine LacassagneTerminated
-
AmgenMerck Sharp & Dohme LLCTerminatedMelanomaUnited States, Finland, France, Germany, Italy, Canada, Czechia, Poland, Switzerland, Korea, Republic of, Russian Federation, United Kingdom, Australia, Netherlands, Spain, Austria, Belgium, Hungary, Portugal, Greece, South Africa
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, FranceCompleted
-
NewLink Genetics CorporationTerminated
-
Zuyderland Medisch CentrumCompleted
-
Bristol-Myers SquibbCompletedMelanomaCanada, Australia, Germany, Italy, Poland, France, Denmark, Argentina, Chile, Spain, Norway, Israel, Sweden, Mexico, Greece, Finland
-
University of Wisconsin, MadisonNational Cancer Institute (NCI)CompletedMelanomaUnited States
-
Bristol-Myers SquibbCompleted
-
Cellxpert Biotechnology Corp.Medigen Biotechnology CorporationCompleted
-
Bristol-Myers SquibbCompletedMelanomaFrance, Canada, United States, Germany, Australia, Russian Federation, Spain, Italy, Netherlands, Poland, Denmark, Israel, United Kingdom
-
Bristol-Myers SquibbCompletedMelanomaUnited States
-
Gary DoolittleCompleted
-
Yana NajjarMerck Sharp & Dohme LLCTerminatedMelanomaUnited States
-
Institut Claudius RegaudCompleted
-
Massachusetts General HospitalActive, not recruiting
-
Nantes University HospitalBristol-Myers SquibbCompleted
-
Bristol-Myers SquibbWithdrawnMelanomaFrance, Italy, Poland, United States, Brazil, Spain, Australia, Denmark, Germany, Austria, Netherlands, Russian Federation, Belgium, United Kingdom, Sweden, Switzerland
-
Northwestern UniversityCompletedMelanomaUnited States
-
Novartis PharmaceuticalsCompletedMelanomaUnited States, United Kingdom, Austria, Belgium, Hungary, Canada, Netherlands, Argentina, Australia, Brazil, Czechia, Denmark, France, Germany, Israel, Italy, Norway, Poland, Russian Federation, Spain, Switzerland, Taiwan, Korea, Republic... and more
-
Taizhou HoudeAoke Biomedical Co., Ltd.Unknown
-
Peking University Cancer Hospital & InstituteActive, not recruiting
-
University of ChicagoEisai Inc.Terminated
-
GlaxoSmithKlineTerminatedMelanomaNorway, Argentina, Greece
-
M.D. Anderson Cancer CenterTerminated
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)Terminated
-
University of MiamiTerminatedMelanomaUnited States
-
X4 PharmaceuticalsCompleted
-
Centre Hospitalier Universitaire VaudoisLudwig Institute for Cancer ResearchCompleted
-
Centre Hospitalier Universitaire VaudoisImmutep S.A.S.Terminated
-
University of PittsburghSchering-PloughCompleted
-
Peking University Cancer Hospital & InstituteUnknown
-
Regeneron PharmaceuticalsSanofiCompletedMelanomaKorea, Republic of, Serbia, Netherlands, United Kingdom
-
Royal Marsden NHS Foundation TrustUniversity of Leeds; University of ManchesterTerminated
-
Stanford UniversityCompleted
-
Craig L Slingluff, JrCompleted
-
M.D. Anderson Cancer CenterGlaxoSmithKlineCompleted
-
Memorial Sloan Kettering Cancer CenterPfizerCompleted
-
BioNTech RNA Pharmaceuticals GmbHCompleted
-
N.N. Petrov National Medical Research Center of...Terminated
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompleted